Presentations Clinical Update from Phase 1/2 ABILITY Study National Brain Tumor Society's Research Round Table Presentation Medicenna Therapeutics Corp. - Corporate Presentation Q3 2023 Past Events November 16, 2020 at 4:40 PM EST Stifel 2020 Virtual Healthcare Conference Go to November 3, 2020 at 9:50 AM EST Next-Gen Cytokine Therapeutics Summit Go to October 29, 2020 from 11:00 AM to 12:30 PM EDT Virtual TSX Life Sciences Investor Day Go to October 24 - October 25, 2020 Emergence of Novel Long-acting Mono- and Bi-specific IL-2/IL-13 Superkines as Potent Immune Modulators Go to October 24 - October 25, 2020 MDNA55, a Locally Administered IL4 Guided Toxin for Targeted Treatment of Recurrent Glioblastoma Shows Long Term Survival Benefit Go to October 1, 2020 at 12:30 PM EDT Virtual Gravitas Healthcare Investor Day Go to Pagination First page « first Previous page ‹ previous … Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Current page 11 Page 12 Page 13 Next page next › Last page last »
October 24 - October 25, 2020 Emergence of Novel Long-acting Mono- and Bi-specific IL-2/IL-13 Superkines as Potent Immune Modulators Go to
October 24 - October 25, 2020 MDNA55, a Locally Administered IL4 Guided Toxin for Targeted Treatment of Recurrent Glioblastoma Shows Long Term Survival Benefit Go to
